A New Study Supports the Prognostic Value of the Pca3 Prostate …
( TSX : CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, reported today that PCA3, the Company’s highly specific prostate cancer marker, is featured in an important …
[Continue Reading]
Tags: cancer marker, diagnostic tests, laboratory services, life sciences company, prostate cancer